Serial Number | 98116944 |
Word Mark | RADDISH |
Filing Date | Friday, August 4, 2023 |
Status | 730 - FIRST EXTENSION - GRANTED |
Status Date | Friday, April 11, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 20, 2024 |
Goods and Services | Charitable fundraising; Charitable fundraising for Alzheimer's disease and neurodegenerative disease research and treatment |
Goods and Services | Promoting public awareness of Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases and issues related thereto in the nature of patient registries, patient research, patient advocacy and patient fundraising efforts; Promoting public awareness of health care issues for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases, and the importance of patient registration on Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease registries; Charitable services, namely, organizing and developing programs that aim to improve the lives of patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease patients, their caregivers and families; Charitable business services, namely, administration of programs for enabling participants to receive services for Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease patients, their caregivers and families; Business services, namely, recruitment of participants for neuroscience clinical research; Maintaining a registry of participants for neuroscience clinical research relating to the treatment and prevention of brain disease; Promoting participation in clinical trials and research in the neuroscience field; Recruitment advertising services, namely, advertising clinical trials for the purpose of recruiting patients and placing patients for participation in clinical trials in the neuroscience field |
Goods and Services | Healthcare services; Healthcare services, namely, administering care to patients; Healthcare services, namely, administering care to patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, administering tests for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, taking samples from patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Establishing tissue, bloods, organ, and stem cell bank of biological samples related to Alzheimer's neurodegenerative diseases and other neurological and central nervous system diseases; Providing health screening services in the field of Alzheimer's, neurodegenerative diseases, and other neurological and central nervous system diseases; Providing health screening services related to Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases |
Goods and Services | Scientific research in the nature of conducting clinical trials and research for others in the field of Alzheimer's, neuro degenerative diseases and other neurological and central nervous system diseases; Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, September 3, 2023 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, July 8, 2024 |
Primary Code | 036 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, July 8, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, July 8, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Global Alzheimer's Platform Foundation Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Washington, DC 20005 |
Party Name | Global Alzheimer's Platform Foundation Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Washington, DC 20005 |
Event Date | Event Description |
Monday, April 8, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, August 8, 2023 | NEW APPLICATION ENTERED |
Sunday, September 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, April 5, 2024 | ASSIGNED TO EXAMINER |
Monday, April 8, 2024 | NON-FINAL ACTION E-MAILED |
Monday, April 8, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, July 8, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, July 8, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, July 8, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, July 16, 2024 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, July 16, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, July 31, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, October 15, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Friday, April 11, 2025 | SOU TEAS EXTENSION RECEIVED |
Friday, April 11, 2025 | SOU EXTENSION 1 FILED |
Saturday, April 12, 2025 | SOU EXTENSION 1 GRANTED |
Saturday, April 12, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, July 16, 2024 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, July 16, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, July 17, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, August 20, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, August 20, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |